News

Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More
Highlighted opportunities include NANO Nuclear Energy's niche potential, Christian Dior SE's LVMH exposure, and Harrow's ...
The Pharma Letter1d
Samsung Bioepis partners with Harrow on biosimilars in USA
South Korea’s Samsung Bioepis today announced it has entered into a license, development and commercialization agreement (DCA ...
Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it has entered into a ...
10 Health Care Stocks Whale Activity In Today's Session
Here's the list of options activity happening in today's session: These bullet-by-bullet explanations have been constructed using the accompanying table.
The Malaysian Reserve3d
HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, July 15, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that ...
Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?
Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...
The Bakersfield Californian4d
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW). Such investors are advised ...